Mitchell, Helen,Wood, Harold B.,Li, Chun Sing,Mao, Qinghua,Qi, Zhiqi
申请号：
AU2015236438
公开号：
AU2015236438A1
申请日:
2015.03.23
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention is directed to a bicyclic heteroaryl benzamide compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
